Unlocking the Potential of Anti-TIGIT Therapy-Between Promise and Challenges
JAMA Oncol
.
2023 Nov 1;9(11):1503-1504.
doi: 10.1001/jamaoncol.2023.3835.
Authors
Joud Hajjar
1
,
Mohamed H Derbala
2
,
Aung Naing
2
Affiliations
1
Division of Immunology, Allergy & Retrovirology, Baylor College of Medicine, Texas Children's Hospital, Houston.
2
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
PMID:
37768657
DOI:
10.1001/jamaoncol.2023.3835
No abstract available